The Patent Finder

Zynerba Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Zynerba Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.

Showing 1 to 8 of 8 · Back to Zynerba Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 12,213,951Treatment of Autism with Cannabidiol
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,226,373Treatment of Fragile X Syndrome with Cannabidiol
Formerly held
In force
 · Low confidence
In forceLow confidence
US 12,186,282Treatment of 22Q11.2 Deletion Syndrome with Cannabidiol
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,508,270Treatment of Behavioral Impairment in Developmental and Epileptic Encephalopathy
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,449,908Transdermal Delivery of Cannabidiol
Term ended
Term ended Mar 16, 2026 · Medium confidence
Term endedTerm ended Mar 16, 2026Medium confidence
US 8,481,560Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
Formerly held
Lapsed on the fee record
Ended Jul 9, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 9, 2025From the USPTO record
US 8,435,556Transdermal Delivery of Cannabidiol
Formerly held
Term ended
Term ended Jun 24, 2023 · Medium confidence
Term endedTerm ended Jun 24, 2023Medium confidence
US 9,533,942Use of cannabidiol prodrugs in topical and transdermal administration with microneedles
Formerly held
Surrendered on reissue
Surrendered on reissue Mar 3, 2020 · From the USPTO record
Surrendered on reissueSurrendered on reissue Mar 3, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited